Merck KGaA, BMS To Co-Market Glucophage Diabetes Drug In China
This article was originally published in PharmAsia News
Executive Summary
Merck KGaA said it and Bristol-Myers Squibb have agreed to join forces to market diabetes drug Glucophage in China and follow with an extended-release version soon after.